RxDoctor Payments Data

Robert Hamilton

Adult Health · Somerville, NJNPI 1386901080

Payments from drug & device makers

$3,657in general payments, 2019–2025

Across 158 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Antares Pharma, Inc.$1K
  • Intuitive Surgical$617
  • Astellas Pharma US Inc$440
  • Tolmar, Inc.$318
  • Coloplast$226
  • Johnson & Johnson$153
  • plus $637 from 16 others

What the payments were for

  • Speaking & faculty fees$160%
  • Travel & lodging$57116%
  • Food & beverage$2,85778%
  • Education$2146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,657 in reported general payments places this provider in the 90th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$75,383
Medicare patients
367
Services billed
6,725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XyostedTestosterone Enanthate178$150,803
Testosterone94$29,017
TlandoTestosterone Undecanoate11$6,997
MyrbetriqMirabegron11$6,304
Testosterone Cypionate52$2,937
Silodosin13$1,821
Tamsulosin Hcl75$1,354
Testosterone Enanthate22$1,351
Solifenacin Succinate11$788
Insulin SyringeSyringe-Needle,insulin,0.5 Ml40$494
Finasteride17$440
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$294
Ciprofloxacin Hcl43$244
Insulin SyringeSyringe And Needle,insulin,1ml18$204
CefuroximeCefuroxime Axetil17$181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Antares Pharma, Inc.Xyosted, Tlando$1,267$157,800189 claims
Astellas Pharma US IncMyrbetriq$440$6,30411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Somerville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →